Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VANDA PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 46.46 M 85.17 M 31.87 M 31.15 M 16.26 M
    Net Receivables 678,808.00 1.06 M 1.03 M 0.00 0.00
    Total Inventories 0.00 0.00 0.00 0.00 0.00
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses 608,592.00 717,929.00 924,025.00
    Other Current Assets 0.00 0.00 0.00 2.22 M 190,604.00
    Current Assets Total 47.75 M 86.96 M 33.82 M 33.37 M 16.45 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 430,230.00 8.56 M 430,230.00 1.27 M 0.00
    Property, Plant & Equipment Net 1.76 M 1.35 M 1.86 M 1.11 M 1.25 M
    Property, Plant & Equipment Gross 3.67 M 2.73 M 3.32 M 1.99 M 1.71 M
    Accumulated Depreciation 1.92 M 1.39 M 1.46 M 883,292.00 462,274.00
    Other Assets 0.00 0.00 150,000.00 0.00 50,000.00
    Deferred Charges
    Tangible Other Assets 0.00 0.00 150,000.00 0.00 50,000.00
    Intangible Other Assets 0.00 0.00 0.00 0.00 0.00
    Total Assets 49.93 M 96.86 M 36.26 M 35.75 M 17.75 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 0.00 0.00 142,461.00 211,170.00
    Accrued Payroll 126,816.00 1.13 M 1.16 M 576,374.00 317,823.00
    Income Taxes Payable
    Dividends Payable
    Other Current Liabilities 2.77 M 8.66 M 5.16 M 2.09 M 375,154.00
    Current Liabilities Total 3.41 M 12.78 M 9.11 M 5.06 M 1.62 M
    Long Term Debt 0.00 0.00 0.00 0.00 155,530.00
    Provision for Risks & Charges
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 502,770.00 0.00 129,950.00 0.00 0.00
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 0.00 354,042.00 267,397.00 24,433.00 30,371.00
    Total Liabilities 3.91 M 13.13 M 9.50 M 5.09 M 1.81 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 61.80 M
    Common Equity 46.02 M 83.73 M 26.76 M -31.13 M 15.94 M
    Common Stock 26,653.00 26,653.00 22,129.00 99.00
    Capital Surplus 270.99 M 257.60 M 126.58 M 23.98 M
    Revaluation Reserves
    Other Appropriated Reserves -20,029.00 12,176.00 -3,269.00 -18.78 M
    Unappropriated (Free) Reserves 0.00
    Retained Earnings -224.97 M -173.91 M -99.84 M -36.33 M
    Equity in Untaxed Reserves
    ESOP Guarantees
    Unrealized Foreign Exchange Gain (Loss) -17,609.00
    Unrealized Gain (Loss) on Marketable Securities
    Treasury Stock 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 49.93 M 96.86 M 36.26 M 35.75 M 17.75 M
    Common Shares Outstanding 26.65 M 26.65 M 22.13 M 71.63 M 71.63 M